Depressive symptoms in neurodegenerative diseases

被引:116
|
作者
Baquero, Miquel [1 ]
Martin, Nuria [1 ]
机构
[1] Hosp Univ & Politecn La Fe, Serv Neurol, Avinguda F Abril Martorell,106, Valencia 46026, Spain
关键词
Neurodegenerative diseases; Alzheimer; Depressive symptoms; Frontotemporal degeneration; Vascular dementia; Lewy body disease; Depression; Dementia; MILD COGNITIVE IMPAIRMENT; PROVISIONAL DIAGNOSTIC-CRITERIA; LATE-LIFE DEPRESSION; BRIEF CLINICAL FORM; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEUROPSYCHIATRIC INVENTORY; FRONTOTEMPORAL DEMENTIA; VASCULAR DEMENTIA; LEWY BODIES;
D O I
10.12998/wjcc.v3.i8.682
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depressive symptoms are very common in chronic conditions. This is true so for neurodegenerative diseases. A number of patients with cognitive decline and dementia due to Alzheimer's disease and related conditions like Parkinson's disease, Lewy body disease, vascular dementia, frontotemporal degeneration amongst other entities, experience depressive symptoms in greater or lesser grade at some point during the course of the illness. Depressive symptoms have a particular significance in neurological disorders, specially in neurodegenerative diseases, because brain, mind, behavior and mood relationship. A number of patients may develop depressive symptoms in early stages of the neurologic disease, occurring without clear presence of cognitive decline with only mild cognitive deterioration. Classically, depression constitutes a reliable diagnostic challenge in this setting. However, actually we can recognize and evaluate depressive, cognitive or motor symptoms of neurodegenerative disease in order to establish their clinical significance and to plan some therapeutic strategies. Depressive symptoms can appear also lately, when the neurodegenerative disease is fully developed. The presence of depression and other neuropsychiatric symptoms have a negative impact on the quality-of-life of patients and caregivers. Besides, patients with depressive symptoms also tend to further decrease function and reduce cognitive abilities and also uses to present more affected clinical status, compared with patients without depression. Depressive symptoms are treatable. Early detection of depressive symptoms is very important in patients with neurodegenerative disorders, in order to initiate the most adequate treatment. We review in this paper the main neurodegenerative diseases, focusing in depressive symptoms of each other entities and current recommendations of management and treatment.
引用
收藏
页码:682 / 693
页数:12
相关论文
共 50 条
  • [21] Cerebral correlates of psychotic syndromes in neurodegenerative diseases
    Jellinger, Kurt A.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2012, 16 (05) : 995 - 1012
  • [22] Trajectories of neuropsychiatric symptoms over time in healthy volunteers and risk of MCI and dementia
    Leoutsakos, Jeannie-Marie S.
    Wise, Elizabeth A.
    Lyketsos, Constantine G.
    Smith, Gwenn S.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 34 (12) : 1865 - 1873
  • [23] Associations between Depression, Depressive Symptoms, and Incidence of Dementia in Latin America: A 10/66 Dementia Research Group Study
    Johansson, Lena
    Guerra, Mariella
    Prince, Martin
    Horder, Helena
    Falk, Hanna
    Stubbs, Brendon
    Prina, A. Matthew
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (02) : 433 - 441
  • [24] Five-class differential diagnostics of neurodegenerative diseases using random undersampling boosting
    Tong, Tong
    Ledig, Christian
    Guerrero, Ricardo
    Schuh, Andreas
    Koikkalainen, Juha
    Tolonen, Antti
    Rhodius, Hanneke
    Barkhof, Frederik
    Tijms, Betty
    Lemstra, Afina W.
    Soininen, Hilkka
    Remes, Anne M.
    Waldemar, Gunhild
    Hasselbalch, Steen
    Mecocci, Patrizia
    Baroni, Marta
    Lotjonen, Jyrki
    van der Flierd, Wiesje
    Rueckert, Daniel
    NEUROIMAGE-CLINICAL, 2017, 15 : 613 - 624
  • [25] Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
    Rosen, Christoffer
    Mattsson, Niklas
    Johansson, Per M.
    Andreasson, Ulf
    Wallin, Anders
    Hansson, Oskar
    Johansson, Jan-Ove
    Lamont, John
    Svensson, Johan
    Blennow, Kaj
    Zetterberg, Henrik
    FRONTIERS IN AGING NEUROSCIENCE, 2011, 3
  • [26] The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention
    Huang, Yunhong
    Todd, Nicholas
    Thathiah, Amantha
    CURRENT OPINION IN PHARMACOLOGY, 2017, 32 : 96 - 110
  • [27] Therapeutic Potential and Molecular Mechanisms of Echinacoside in Neurodegenerative Diseases
    Li, Jin
    Yu, Hongni
    Yang, Chuan
    Ma, Tao
    Dai, Yuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review
    Drijgers, Rosa L.
    Aalten, Pauline
    Winogrodzka, Ania
    Verhey, Frans R. J.
    Leentjens, Albert F. G.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (01) : 13 - 22
  • [29] Oxidative Imbalance in Different Neurodegenerative Diseases with Memory Impairment
    Gironi, M.
    Bianchi, A.
    Russo, A.
    Alberoni, M.
    Ceresa, L.
    Angelini, A.
    Cursano, C.
    Mariani, E.
    Nemni, R.
    Kullmann, C.
    Farina, E.
    Boneschi, F. Martinelli
    NEURODEGENERATIVE DISEASES, 2011, 8 (03) : 129 - 137
  • [30] Sex-Specific Associations Between Depressive Symptoms and Risk for Subsequent Dementia
    Heser, Kathrin
    Kleineidam, Luca
    Pabst, Alexander
    Wiese, Birgitt
    Roehr, Susanne
    Loebner, Margrit
    Hajek, Andre
    van der Leeden, Carolin
    Angermeyer, Matthias C.
    Scherer, Martin
    Koenig, Hans-Helmut
    Maier, Wolfgang
    Riedel-Heller, Steffi G.
    Wagner, Michael
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 151 - 161